Literature DB >> 20075092

Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

C Heyn1, J Poublanc, A Crawley, D Mandell, J S Han, M Tymianski, K terBrugge, J A Fisher, D J Mikulis.   

Abstract

BACKGROUND AND
PURPOSE: BOLD MR imaging combined with a technique for precision control of end-tidal pCO(2) was used to produce quantitative maps of CVR in patients with Moyamoya disease. The technique was validated against measures of disease severity by using conventional angiography; it then was used to study the relationship between CVR, vascular steal, and disease severity.
MATERIALS AND METHODS: A retrospective analysis comparing conventional angiography with BOLD MR imaging was performed on 11 patients with Moyamoya disease. Iso-oxic cycling of end-tidal pCO(2) between 2 target values was performed during BOLD MR imaging. CVR was calculated as the BOLD signal difference per Delta pCO(2). CVR was correlated with the presence of Moyamoya or pial collaterals and the degree of Moyamoya disease as graded by using a modified Suzuki score.
RESULTS: A good correlation between mean CVR and Suzuki score was found for the MCA and ACA territories (Pearson correlation coefficient, -0.7560 and -0.6140, respectively; P < .0001). A similar correlation was found between mean CVR and the presence of pial and Moyamoya collateral vessels for combined MCA and ACA territories (Pearson correlation coefficient, -0.7466; P < .0001). On a voxel-for-voxel basis, there was a greater extent of steal within vascular territories with increasing disease severity (higher modified Suzuki score). Mean CVR was found to scale nonlinearly with the extent of vascular steal.
CONCLUSIONS: Quantitative measures of CVR show direct correlation with impaired vascular supply as measured by the modified Suzuki score and enable direct investigation of the physiology of autoregulatory reserve, including steal phenomenon, within a given vascular territory.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075092      PMCID: PMC7964198          DOI: 10.3174/ajnr.A1922

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  MRI mapping of cerebrovascular reactivity using square wave changes in end-tidal PCO2.

Authors:  A Vesely; H Sasano; G Volgyesi; R Somogyi; J Tesler; L Fedorko; J Grynspan; A Crawley; J A Fisher; D Mikulis
Journal:  Magn Reson Med       Date:  2001-06       Impact factor: 4.668

2.  Predominant involvement of ipsilateral anterior and posterior circulations in moyamoya disease.

Authors:  Shunji Mugikura; Shoki Takahashi; Shuichi Higano; Reizo Shirane; Yoshiharu Sakurai; Shogo Yamada
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

3.  Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease.

Authors:  Y Kuwabara; Y Ichiya; M Sasaki; T Yoshida; K Masuda; T Matsushima; M Fukui
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

4.  Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery.

Authors:  Young So; Ho-Young Lee; Seung-Ki Kim; Jae Sung Lee; Kyu-Chang Wang; Byung-Kyu Cho; Eunjoo Kang; Dong Soo Lee
Journal:  Stroke       Date:  2005-06-09       Impact factor: 7.914

5.  Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI.

Authors:  Daniel M Mandell; Jay S Han; Julien Poublanc; Adrian P Crawley; Jeff A Stainsby; Joseph A Fisher; David J Mikulis
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

6.  Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT.

Authors:  Shiro Yamamoto; Manabu Watanabe; Toshihiko Uematsu; Kenichiro Takasawa; Masaru Nukata; Naokazu Kinoshita
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

7.  Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation.

Authors:  K H Kang; H S Kim; S Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

8.  Prospective targeting and control of end-tidal CO2 and O2 concentrations.

Authors:  Marat Slessarev; Jay Han; Alexandra Mardimae; Eitan Prisman; David Preiss; George Volgyesi; Cliff Ansel; James Duffin; Joseph A Fisher
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

  8 in total
  30 in total

1.  Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease.

Authors:  Carlos C Faraco; Megan K Strother; Lindsey M Dethrage; Lori Jordan; Robert Singer; Paul F Clemmons; Manus J Donahue
Journal:  Magn Reson Med       Date:  2014-04-22       Impact factor: 4.668

2.  Correlating hemodynamic magnetic resonance imaging with high-field intracranial vessel wall imaging in stroke.

Authors:  Weston Langdon; Manus J Donahue; Anja G van der Kolk; Swati Rane; Megan K Strother
Journal:  J Radiol Case Rep       Date:  2014-06-30

3.  Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.

Authors:  Manus J Donahue; Michael Ayad; Ryan Moore; Matthias van Osch; Robert Singer; Paul Clemmons; Megan Strother
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

Review 4.  Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging.

Authors:  J J Pillai; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-30       Impact factor: 3.825

5.  Bolus arrival time and cerebral blood flow responses to hypercarbia.

Authors:  Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

6.  Imaging of cerebrovascular reserve and oxygenation in Moyamoya disease.

Authors:  Wendy W Ni; Thomas Christen; Jarrett Rosenberg; Zungho Zun; Michael E Moseley; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI.

Authors:  Domenico Zacà; Jorge Jovicich; Sreenivasan R Nadar; James T Voyvodic; Jay J Pillai
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

8.  Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.

Authors:  N Dlamini; M Slim; F Kirkham; M Shroff; P Dirks; M Moharir; D MacGregor; A Robertson; G deVeber; W Logan
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

9.  Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.

Authors:  Travis R Ladner; Manus J Donahue; Daniel F Arteaga; Carlos C Faraco; Brent A Roach; L Taylor Davis; Lori C Jordan; Michael T Froehler; Megan K Strother
Journal:  J Neurosurg       Date:  2016-03-11       Impact factor: 5.115

10.  Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting.

Authors:  Arnaud Attyé; Marjorie Villien; Florence Tahon; Jan Warnking; Olivier Detante; Alexandre Krainik
Journal:  Hum Brain Mapp       Date:  2013-02-21       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.